Original ArticleCorrelation of CD4+ T cell Count with Total Lymphocyte Count, Haemoglobin and Erythrocyte Sedimentation Rate Levels in Human Immunodeficiency Virus Type-1 Disease
Introduction
As per the 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS among adolescents and adults [1], the clinical importance of CD4 counts in HIV-disease staging has been emphasized.
The World Health Organization (WHO) currently recommends initiation of antiretroviral therapy (ART) in people living with HIV/AIDS (PLHA) with CD4 T-lymphocyte counts <350 cells/mm3 irrespective of the WHO clinical staging [2]. In India, however, as per the National AIDS Control Organization (NACO) recommendations, initiation of ART should be considered if CD4 cell counts are less than 350/mm3 and in those with symptomatic HIV disease and CD4 cell counts between 200-350/mm3 [3].
Obtaining CD4 counts requires the use of expensive tools, which are not readily available in resource-limited settings. The identification of laboratory tests that help the clinician to predict progression is useful not only to monitor the patients’ disease evolution but also to define the appropriate time to initiate treatment.
According to the WHO guidelines [4], in the absence of CD4 counts, total lymphocyte count (TLC) <1200/mm3, though a less useful substitute, can be used for starting ART in individuals with symptomatic HIV disease. There are studies in HIV-infected adults that have demonstrated association of TLC <1200/mm3 and subsequent disease progression or mortality [5, 6, 7] as well as those which propose that the rate of TLC decline should be used in disease monitoring [7, 8]. However, it is important to note that the WHO continues to recommend CD4 count as the main laboratory measurement for making decisions about when to start, stop, and change ART [4].
There are studies which have investigated the association of other surrogate markers such as haemoglobin (Hb), and erythrocyte sedimentation rate (ESR) with CD4 count and disease progression. In a study from Africa, ESR has been demonstrated to have a strong negative association with CD4 count [9]. While the rates of decrease in Hb have been reported to correlate with falling CD4 counts [5, 6], there have been suggestions that increases in haemoglobin are predictive of treatment success when combined with an increase in TLC [8].
This study aimed to find out the relationship of CD4 counts with TLC, Hb and ESR and whether these parameters can be used as substitute surrogate markers for CD4-positive T lymphocyte counts in HIV-infected individuals.
Section snippets
Material And Methods
The study was a cross sectional pilot study, wherein the participants were HIV-1 positive adults admitted to, or attending outpatient departments at a tertiary care hospital between May and July 2009 (n=215). Those HIV-1 infected individuals who were previously ART-experienced were excluded from the study.
The blood and serum samples were collected after obtaining informed consent. The TLCs of study participants were measured using the Beckman Coulter AcT Diffuse II Haematology Analyzer.
Results
The study population comprised of 215 HIV-1 infected adult individuals of whom 179 were males and 36 females. The median age of the study population was 35 years (range: 24-60 years).
The scatter diagram in Fig. 1 depicts the distribution of the CD4+ T lymphocytes when plotted against the TLCs, Hb levels and ESRs of the study participants.
Spearman's rank order correlation was applied as a statistical test of significance on the different study population categories based on their respective CD4+
Discussion
Spacek et al [12] (2003) studied the ability of TLC and Hb to predict CD4 count. A total of 3,269 individuals from the Johns Hopkins HIV Observational Cohort were evaluated retrospectively. While the cut off values for TLC below 1200 cells/mm3 and haemoglobin below 12 g/dl significantly predicted CD4 cell counts below 200 cells/mm3, for TLC alone, the sensitivity and specificity were reported as 70.7 and 81.7%, respectively. This study concluded that TLC <1200 cells/mm3 was associated with CD4
Conflicts of Interest
Part of this research work was submitted as a Maharashtra University of Health Sciences, Nashik sponsored short term research studentship project report by Dr Akshat Vyas under the discipline of Microbiology under the guidance of Lt Col S Sen.
Intellectual Contribution of Authors
Study Concept: Lt Col Sourav Sen, Lt Col Sunil Sanghi, Col K Shanmuganandan, Col RB Batra
Drafting & Manuscript: Lt Col Sourav Sen, Surg Cmde AK Praharaj, Brig Ketoki Kapila, Col RM Gupta, Akshat Vyas, Col Satish Kumar
Statistical Analysis: Lt Col Sourav Sen
Tecnical Support: Lt Col Sourav Sen, Col RB Batra
Study Supervision: Lt Col Sourav Sen, Brig Ketoki Kapila
Acknowledgements
The authors thank Mr. D.R. Basannar, Scientist E and Mrs. Seema Patrikar, Department of Community Medicine, Armed Forces Medical College, Pune, for providing guidance on statistical analyses.
References (22)
- et al.
Determining eligibility for antiretrovira1 therapy in resource-limited settings using total lymphocyte counts, haemoglobin and body mass index
AIDS Res Ther
(2007) Interim WHO Clinical Staging of HIV/AIDS and HIV/AIDS Case Definitions for Surveillance (Internet). 2005 (cited 2009)
Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach — 2010 rev. (Monograph online)
(2010)Antiretroviral therapy guidelines for HIV-infected adults and adolescents including post-exposore prophylaxis (Monograph online)
(2007)WHO: Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach —2003 revision (Monograph online)
(2004)- et al.
Total lymphocyte count, haemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy
J Acquir Immune Defic Syndr
(2004) - et al.
HIV-1 subtype E progression among northern Thai couples: traditional and non-traditional predictors of survival
Int J Epidemiol
(2005) - et al.
Use of total lymphocyte count and haemoglobin concentration for monitoring progression of HIV infection
J Acquir Immune Defic Syndr
(2005) - et al.
Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy
AIDS
(2003) - et al.
Relation between erythrocyte sedimentation rate, clinical and immune status in HIV-infected patients
Niger J Med
(2008)
Cited by (9)
Utility of absolute lymphocyte count as a surrogate marker of CD4 cell counts: Is it useful?
2014, Medical Journal Armed Forces IndiaCitation Excerpt :However in the recent past there has again been a resurgence of studies published which advocate the utility of ALC as a proxy marker for CD4 estimation in management of HIV/AIDS.2 Multiple studies in the past including one by Sen S et al, in 2011 did not validate ALC as an effective surrogate marker of CD4 lymphocyte counts.1 They suggested more work at a different centre, on the subject, to validate their outcome.
Better Predictive Value of Lymphocyte Count and Hemoglobin for CD4 Level of HIV Patients
2023, Current HIV ResearchAn Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa
2019, Infectious Diseases and TherapyCD4 cell counts, lipid profile, and oral manifestations in HIV-infected and AIDS patients
2019, Frontiers in DentistryCovariate random effects on the CD4 count variation during HIV disease progression in women
2019, HIV/AIDS - Research and Palliative CareCD4 cell counts and oral manifestations in HIV infected and AIDS patients
2018, Journal of Oral and Maxillofacial Pathology